Загрузка...
Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
Idiopathic pulmonary fibrosis is a fatal form of progressive fibrosing interstitial pneumonia with limited treatment options. In recent years, its management has been transformed with the approval of two new antifibrotic drugs: nintedanib and pirfenidone. Nintedanib is a tyrosine kinase inhibitor th...
Сохранить в:
| Опубликовано в: : | Drugs R D |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833905/ https://ncbi.nlm.nih.gov/pubmed/29209910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0221-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|